Lee’s Pharma to Distribute Recordati Hypertension Drug
March 16, 2010 at 00:03 AM EDT
Lee's Pharmaceutical Holdings Limited, which is headquartered in Hong Kong, signed an exclusive license for China distribution of a Recordati S.p.A. antihypertensive drug, Zanidip® (lercanidipine). Zanidip is a calcium channel blocker (CCB). Terms of the agreement were not disclosed. More details... Stock Symbols: (GEM: 8221) (MI: RECI)
